Vardan T. Karamyan

NeuroscienceBiochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 10 papers. Top paper: “In-Vivo and Ex-Vivo Brain Uptake Studies of Peptidomimetic Neurolysin Activators in Healthy and Stroke Animals”.

In-Vivo and Ex-Vivo Brain Uptake Studies of Peptidomimetic Neurolysin Activators in Healthy and Stroke Animals

Pharmaceutical Research(2022)10.1007/s11095-022-03218-w

N/A

0DataRank · unranked

12 citations

Shiva Hadi Esfahani, Behnam Noorani, Dhaval Patel, Heidi Villalba, Yashwardhan Ghanwatkar +7 more

Is Diminazene an Angiotensin-Converting Enzyme 2 (ACE2) Activator? Experimental Evidence and Implications

Journal of Pharmacology and Experimental Therapeutics(2022)10.1124/jpet.122.001339

N/A

0DataRank · unranked

7 citations

Srinidhi Jayaraman, Vardan T. Karamyan, Shiva Hadi Esfahani

Structure-activity relationship studies of functionalized aromatic peptidomimetics as neurolysin activators

Bioorganic & Medicinal Chemistry Letters(2022)10.1016/j.bmcl.2022.128669

N/A

0DataRank · unranked

7 citations

Shiva Hadi Esfahani, Saeideh Nozohouri, Shikha Kumari, Joanna Kocot, Yong Zhang +4 more

Estrogen Metabolite 2-Methoxyestradiol Attenuates Blood Pressure in Hypertensive Rats by Downregulating Angiotensin Type 1 Receptor

Frontiers in Physiology(2022)10.3389/fphys.2022.876777

N/A

0DataRank · unranked

2 citations

Benard O. Ogola, Laxmi Iyer, Vardan T. Karamyan, Thomas Thekkumkara, Yong Zhang

Challenges with the proposed ACE2 activation mechanism of diminazene aceturate

Clinical and Experimental Pharmacology and Physiology(2022)10.1111/1440-1681.13636

N/A

0DataRank · unranked

0 citations

Vardan T. Karamyan, Shiva Hadi Esfahani

Discovery of the Next Generation of Non-peptidomimetic Neurolysin Activators with High Blood-Brain Barrier Permeability: a Pharmacokinetics Study in Healthy and Stroke Animals

Pharmaceutical Research(2023)10.1007/s11095-023-03619-5

N/A

0DataRank · unranked

6 citations

Sejal Sharma, Shirisha Jonnalagadda, Shikha Kumari, Aarfa Queen, Shiva Hadi Esfahani +7 more

High brain-blood barrier permeability highlights a new class of neurolysin activators as promising candidates for stroke treatment: a pilot pharmacokinetic study in mice

Journal of Pharmacology and Experimental Therapeutics(2023)10.1124/jpet.122.533120

N/A

0DataRank · unranked

0 citations

Sejal Sharma, Shiva Hadi Esfahani, Shirisha Jonnalagadda, Aarfa Queen, Saeideh Nozohouri +5 more

Evaluation of systemic and brain pharmacokinetic parameters for repurposing metformin using intravenous bolus administration

Journal of Pharmacology and Experimental Therapeutics(2024)10.1124/jpet.124.002152

N/A

0DataRank · unranked

10 citations

Yong Zhang, Dhavalkumar Patel, Khondker Ayesha Akter, Sounak Bagchi, Ali Ehsan Sifat +5 more

Structural basis of divergent substrate recognition and inhibition of human neurolysin

Scientific Reports(2024)10.1038/s41598-024-67639-w

N/A

0DataRank · unranked

2 citations

Sounak Bagchi, Jordis Bickel, Shiva Hadi Esfahani, Lulu Yin, Tiffany Cheng +3 more

The Missing Enzymes: A Call to Update Pharmacological Profiling Practices for Better Drug Safety Assessment

Journal of Medicinal Chemistry(2025)10.1021/acs.jmedchem.4c02228

N/A

0DataRank · unranked

3 citations

Vardan T. Karamyan, Monika Maciąg